MFX

Medical Technologies & Devices

Website: https://mfx.bio/contact/
Membership category: Emerging Y3

Flat 4, 36 Clifton Gardens, London, W9 1AU, United Kingdom

MFX at a glance

MFX develops an innovate bioreactor bringing the superior efficiencies and process control of microfluidics to large scale cell culture

About MFX

MFX is tackling the problems of process control, scalability and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, close technology allows biologists to easily carry out process development by running dozens of cell culture conditions in parallel with extreme process control, and to scale up seamlessly up to several billion cells for manufacturing at a fraction of the current costs.

Therapeutic area(s)

ATMP

Articles MFX has contributed to

5 December 2022

Expanding MicrofluidX through Future Leaders Fellowships

Meet Cesare M. Cejas, co-founder and Vice-President - Microfluidics for MicrofluidX. Together with his co-founder, he set up a start-up in London to leverage microfluidics-based applications for cell and gene therapy applications, particularly autologous cell therapy. Read this Q&A blog about his experience of Future Leaders Fellowships (FLF) Round 5, which is a personal award offered by UKRI to support fellows to develop as impactful and influential research or innovation leaders.

Blog